TrialAlimentary pharmacology & therapeutics2015

Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy.

N J Shaheen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.